It was always a high risk/high reward punt and the science managers took a big gamble for all of us. Ultimately, the whole strategy depended on re-purpose well-established drugs for some lesser indications/benefits, and developing to a stage when bigger boys with development funds will buy into the value-added propositions. I guess the big boys are not interested. We might have to just turn out the lights.
It was always a high risk/high reward punt and the science...
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 9849314 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 6053724 | 25 |
View Market Depth
| Last trade - 16.12pm 11/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |
Day chart unavailable